Trial Profile
A Study to Evaluate the Efficacy and Safety of Febuxostat in Chronic Kidney Disease with Asymptomatic Hyperuricemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Renal failure
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2016 New trial record